LEO Pharma is a world leader in dermatological (skin) and thrombotic (blood clot) care, meeting unmet medical needs which benefit millions of people around the world. With a commitment to undertake innovative research and a pledge to always have people at the heart of everything we do, we strive to improve lives through high ethical standards and empowering people with these conditions to have a better quality of life.
Through listening to those that we are committed to serving, we can better support people by delivering holistic solutions that go beyond medical fundamentals. After over a century of innovative and ethical research, we understand that tackling life-altering and life-threatening conditions requires a multi-disciplinary approach, including recognising the importance of actively listening to the first-hand experiences of people who live with the conditions that we aim to treat. As part of this, the Voices in Partnership (ViP) Programme facilitates people partnering with LEO Pharma UK/IE in order give vital insights into the conditions that they live with, helping us to develop solutions together. The ViP programme originally had a focus on psoriasis only, but its positive impact has led to the programme now being widened to people living with thrombosis.
LEO is proud of our disease awareness and support programmes that help empower people to have the confidence to take control of their conditions. QualityCare™ offers free and confidential and support to people living with psoriasis and cancer associated thrombosis (CAT).